InsiderClue
← All stocks

Nurix Therapeutics, Inc.

NRIX Scheduled selling only
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.53M
$1.35M on a plan · $3.18M straight out of an exercise
Sold at will
$0.00
0 of 40 sales
Net
−$4.53M
$0.00 against sales at will

By person

4 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
—
$3.26M (20) scheduled
−$3.26M
9,110
0.0088%
$242.67K
−63.0%
van Houte Hans
Chief Financial Officer
—
$635.33K (10) scheduled
−$635.33K
40,166
0.0387%
$1.07M
+29.6%
Hansen Gwenn
Chief Scientific Officer
—
$630.90K (10) scheduled
−$630.90K
117,227
0.1130%
$3.12M
+159.6%
GREGORY JULIA P
Director
—
—
—
10,750
0.0104%
$286.35K
—

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Ring Christine
2 Sep 2026
Chief Legal Officer
Sold after exercise
400
$26.64
$10.66K
Ring Christine
2 Sep 2026
Chief Legal Officer
Sold after exercise
5,387
$25.69
$138.42K
Hansen Gwenn
1 Sep 2026
Chief Scientific Officer
Sold after exercise
1,452
$25.47
$36.98K
Hansen Gwenn
5 Aug 2026
Chief Scientific Officer
Sold after exercise
4,356
$25.00
$108.90K
Ring Christine
3 Aug 2026
Chief Legal Officer
Sold after exercise
16,589
$23.05
$382.36K
Hansen Gwenn
30 Jul 2026
Chief Scientific Officer
Sold after exercise
3,847
$23.38
$89.95K
Ring Christine
30 Jul 2026
Chief Legal Officer
Sold after exercise
3,847
$23.38
$89.95K
van Houte Hans
30 Jul 2026
Chief Financial Officer
Sold after exercise
2,845
$23.38
$66.52K
Ring Christine
2 Jul 2026
Chief Legal Officer
Sold after exercise
11,008
$23.56
$259.37K
Ring Christine
25 Jun 2026
Chief Legal Officer
Sold after exercise
28,935
$20.06
$580.51K
Ring Christine
2 Jun 2026
Chief Legal Officer
Sold after exercise
8,148
$16.60
$135.25K
Hansen Gwenn
30 Apr 2026
Chief Scientific Officer
Sold after exercise
3,214
$16.65
$53.50K
Ring Christine
30 Apr 2026
Chief Legal Officer
Sold after exercise
3,214
$16.65
$53.50K
van Houte Hans
30 Apr 2026
Chief Financial Officer
Sold after exercise
2,388
$16.65
$39.75K
Hansen Gwenn
30 Jan 2026
Chief Scientific Officer
Sold after exercise
98
$17.37
$1.70K
Hansen Gwenn
30 Jan 2026
Chief Scientific Officer
Sold after exercise
4,797
$16.58
$79.55K
Ring Christine
30 Jan 2026
Chief Legal Officer
Sold after exercise
88
$17.37
$1.53K
Ring Christine
30 Jan 2026
Chief Legal Officer
Sold after exercise
4,333
$16.58
$71.85K
van Houte Hans
30 Jan 2026
Chief Financial Officer
Sold after exercise
73
$17.37
$1.27K
van Houte Hans
30 Jan 2026
Chief Financial Officer
Sold after exercise
3,588
$16.58
$59.50K
Ring Christine
20 Jan 2026
Chief Legal Officer
Sold after exercise
3,760
$18.42
$69.27K
Ring Christine
18 Dec 2025
Chief Legal Officer
Sold after exercise
200
$18.56
$3.71K
Ring Christine
18 Dec 2025
Chief Legal Officer
Sold after exercise
3,560
$17.87
$63.60K
Ring Christine
24 Nov 2025
Chief Legal Officer
Sold after exercise
37,600
$17.07
$641.70K
Hansen Gwenn
30 Oct 2025
Chief Scientific Officer
Sold after exercise
4,087
$12.80
$52.30K
Ring Christine
30 Oct 2025
Chief Legal Officer
Sold after exercise
3,644
$12.80
$46.63K
van Houte Hans
30 Oct 2025
Chief Financial Officer
Sold after exercise
3,130
$12.80
$40.05K
Show all 42 transactions →

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 27
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 272,001
History held since 29 Jul 2020